News and Media

Latest News Release
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

Top feature box IMAGE ONLY - COMPANY NEWS

Company News

Cardinal Health Completes Acquisition of Denver Biomedical, a Manufacturer of Specialized Medical Devices
05/23/2006

McGaw Park, Ill., May 23, 2006 -- Cardinal Health, Inc. (NYSE: CAH), the leading provider of products and services supporting the health-care industry, today announced it has completed the acquisition of Denver Biomedical, Inc., a designer and manufacturer of specialized medical products for chronic fluid management in the chest and abdomen. Terms of the agreement were not disclosed. 

 

Based in Golden, Colorado, Denver Biomedical has 50 employees. It markets specialty drainage products worldwide for hospital and home use, primarily for terminally-ill cancer patients. Founded in 1969, Denver Biomedical’s products include the Pleurx® Pleural Catheter System, the Denver® Ascites Shunt, and the Denver® Pleural Effusion Shunt. Denver Biomedical was the first company to receive FDA clearance specifically for an indwelling catheter for drainage of chronic pleural and ascitic fluids.

 

”Well recognized by clinicians, Denver Biomedical’s products are a great fit with our existing business,” said Tom Daulton, vice president and general manager, Special Procedures, Cardinal Health. “These products significantly enhance patient quality of life and reduce hospital costs.”

 

Cardinal Health manufactures and markets a full range of industry-leading devices used in biopsy and spine procedures. It’s major product lines in these areas include the Vertemax Vertebral Augmentation System, Achieve®, Temno® and Tru-Cut® biopsy needles and trays and Jamshidi® lbone marrow biopsy needles.

 

“We take great pride in our products, support to the medical community and our passion for service excellence. After careful consideration, we selected Cardinal Health as a partner that could successfully continue this tradition,” said Bonnie Vivian, president, Denver Biomedical. “We are looking forward to accelerating our growth as part of Cardinal Health.”

 

The chronic fluid drainage market provides a vital service to patients, providing at-home relief for fluid build-up. This acquisition supports Cardinal Health’s strategic focus and rounds out the company’s growing Para/Thoracentesis product offering.

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $75 billion, global company serving the health-care industry with a broad portfolio of products and services. Through its diverse offering, Cardinal Health delivers integrated health-care solutions that help customers reduce their costs, improve efficiency and deliver better care to patients. The company manufactures, packages and distributes pharmaceuticals and medical supplies, offers a range of clinical services and develops automation products that improve the management and delivery of supplies and medication for hospitals, physician offices and pharmacies. Ranked No. 19 on the Fortune 500, Cardinal Health employs more than 55,000 people on six continents. More information about the company may be found at www.cardinalhealth.com.

More Company News
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

04/07/2021

By Victor Crawford, Chief Executive Officer of the Pharmaceutical segment at Cardinal Health

04/07/2021

Cardinal Health (NYSE: CAH) Specialty Solutions today launched Cardinal Health™ Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve...

03/30/2021

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New York Stock Exchange. The company will...

View all company news »

* Required Fields